curve lines
Webinar

The Role of Specific PET PSMA imaging and SBRT in the Management of Prostate Cancer

  • Past
  • 28/04/2021 10:00 Europe/Brussels

In this webinar, the experts highlight the synergy between highly sensitive imaging, the definition of an intermediate stage between non-disseminated tumor and widespread metastatic disease (oligometastatic state) and high-precision radiation therapy (Stereotactic Body Radiation Therapy - SBRT) focused to treat the oligometastatic lesions.

This webinar is already ready over. Missed the live webinar or want to rewatch it? 

Speakers

  • Dr Jeremie Calais
    Dr Jeremie Calais
    Director of the Clinical Research Program of the Nuclear Medicine and Theranostics Division
    UCLA, US
  • Dr Stefan Korber
    Dr Stefan Korber
    MD, PhD First Senior Medical Doctor at Clinic for Radiation Oncology and Radiation Therapy
    University Clinic of Heidelberg, Germany
  • Dr Kai Schubert
    Dr Kai Schubert
    Medical Physicist at Clinic for Radiation Oncology and Radiation Therapy
    University Clinic of Heidelberg, Germany
  • Topics

    • Impact of PSMA PET on management of patients with oligometastatic prostate cancer.

    • The Role of SBRT in the treatment of oligometastatic prostate cancer: Why & how SBRT for these patients.

    • Quality assurance for SBRT treatments.

IBA Webinar, nuclear oncology